GenMark Diagnostics this week announced the appointment of Hany Massarany as president and CEO. Massarany will also join GenMark's board.
Massarany has served as president of Ventana Medical Systems and Head of Roche Tissue Diagnostics since 2009. Ventana was acquired by Roche in February 2008 for about $3.4 billion.
Prior to that, he held various positions with Ventana, including COO, executive vice president of worldwide operations, senior vice president of corporate strategy and development, and vice president of North American commercial operations.
Prior to Ventana, Massarany held executive management positions with Bayer Diagnostics and Chiron Diagnostics. He holds a BS in microbiology and immunology from Monash University and an MBA from Melbourne University.
Fluidigm said this week that Evan Jones has been appointed to the company's board of directors, and will join the board's compensation committee.
Jones is the managing member of jVen Capital, a life sciences investment firm. Prior to that, he was co-founder, chairman, and CEO of Digene. He is currently executive chairman of Opgen; and a board member of CAS Medical Systems and Veracyte.